Overview / Abstract: |
Target Audience Program Overview In the second of a 2-part series, this activity consists of three (3) AliveSimTMpatient simulation case scenarios which will address disease severity and treatment selection in patients with uncontrolled moderate-to-severe asthma. Clinicians will learn through the cases about the inflammatory markers associated with moderate-to-severe asthma, how to individualize and select optimal treatment, and communicate effectively with patients and caregivers about the management of moderate-to-severe asthma. Each scenario will immerse clinicians in “virtual practice sessions” utilizing the AliveSimTMVirtual Practice and Coaching platform, where participants safely practice applying new clinical concepts in asthma. Participants will feel like they’re “in it”, immersed in a series of real-life clinical situations of these patients with asthma. They will interact with virtual peers, make decisions, and receive expert coaching to recognize optimal decision strategies in each scenario. Learning Objectives Assess their competency as they receive expert feedback on decisions |
Expiration |
Dec 13, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.5 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Jonathan Corren MD |
Sponsors / Supporters / Grant Providers |
Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Asthma Free CE CME |